An observational study in Catheter Ablation and Cardiac Arrhythmias, sponsored by National Cerebral and Cardiovascular Center, Japan. Recruiting at 1 site in Japan. Per ClinicalTrials.gov, last updated 2026-11-12.
Sponsored by National Cerebral and Cardiovascular Center, Japan · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 23 studies in Arrhythmias, Cardiac with a site in Japan — 6 open to participants now, 6 under way, none of them phase 3. Arrhythmias, Cardiac · Japan.
Among the 23 studies in Arrhythmias, Cardiac with a site in Japan, this one has the largest planned enrollment of the 15 observational ones that give a count, is one of 3 that started in 2017, is one of 15 observational ones, and was the 18th registered.
1,052 studies on the registry are indexed under Arrhythmias, Cardiac; 236 are open to participants now.
Browse Arrhythmias, Cardiac studies →6 of the 23 studies in Arrhythmias, Cardiac with a site in Japan are open now. Recruiting first, the newest first:
Biotronik, Inc. · Sites in Japan, United States, Australia and 5 more countries
Ages 18+
National Cerebral and Cardiovascular Center, Japan · Sites in Japan
Medtronic · Sites in Japan, United States, Australia and 32 more countries
University of California, Los Angeles · Sites in Japan, United States, Canada and 4 more countries
iRhythm Technologies, Inc. · Sites in Japan
Ages 18+
A study can be open while its sites in Japan have not opened yet or have stopped. Only those recruiting at a site in Japan →
Of the 167 Arrhythmias, Cardiac studies recruiting now, 119 (71%) set no upper age limit and 13 (8%) stop at 75 or younger; 31 take children under 18; 26 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
23 studies; the count open now beside each. This study's row is marked.
First in 1983; this study’s year is marked. 3 started in 2017.
This study's planned enrollment of 400,000 is above the median of 200 across 467 observational studies indexed under Arrhythmias, Cardiac.
Median enrollment 164 across the 8 interventional studies, 1,604 across the 15 observational. Of the 14 that completed or were terminated, 3 (21%) have results posted.
This tab as a report to print or save as PDF → With an account.
17 of 23 have an industry lead sponsor. The 10 most frequent:
National Cerebral and Cardiovascular Center, Japan is the lead sponsor of 19 studies on the registry; 3 are open to participants now.
National Cerebral and Cardiovascular Center, Japan has 2 studies filed under Arrhythmias, Cardiac — fewer than ten, so there is no comparison to draw.
3 of the studies in Arrhythmias, Cardiac with a site in Japan that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04520347University of California, Los AngelesIVTCC 2.0: A Prospective Multicenter Ventricular Tachycardia Catheter Ablation Registry | 2026-12 |
| NCT07118358Biotronik, Inc.BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System | 2027-03 |
| NCT07870837iRhythm Technologies, Inc.Head-to-Head (H2H) Comparison of Ambulatory Cardiac ECG Monitors in Japan | 2027-03-31 |
Add all 3 to your calendar (.ics) → With an account.
Among the 23 studies in Arrhythmias, Cardiac with a site in Japan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Japanese Cather Ablation (J-AB) Registry is a voluntary nationwide registry, performed by Japanese Heart Rhythm Society, collaborated with the National Cerebral and Cardiovascular Center. The objectives of this registry are to observe and describe developments in the catheter ablation treatment of arrhythmia in Japan and to provide reliable information on the type of activity performed and the facilities available in Japanese arrhythmia units.
Japanese Cather Ablation (J-AB) Registry is a nationwide, multicenter, observational registry, performed by Japanese Heart Rhythm Society, collaborated with National Cerebral and Cardiovascular Center.
This study is a voluntary nationwide registry and data are collected prospectively using a Research Electronic Data Capture (REDCap) system. Detailed data collection including antiarrhythmic medication is also performed at every September. The acute success rate at discharge and the complications associated with ablation procedure will be collected in all cases. Major bleeding events are defined according to Bleeding Academic Research Consortium criteria. Based on the provided information, the annual incidence and predictive factors for outcome will be investigated by the event assessment committee.
Inpatients
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Number of patients with recurrence of targeted arrhythmia
Time frame: Through discharge from hospital, approximately up to 1 weeks
Number of deaths
All-cause death, cardiovascular death, and procedure-related death
Time frame: Through discharge from hospital, approximately up to 1 weeks
Number of patients with treatment-related complications
Bleeding events, embolic events, other all complications. Major bleeding events are defined according to Bleeding Academic Research Consortium criteria.
Time frame: 3 months
Started Jul 2017 (actual). Primary completion is estimated for Mar 2030, 152 months after the start.
Of 190 non-industry observational studies under Arrhythmias, Cardiac, half reached primary completion within 45 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 140. This study's planned 152 months is above that.
Counting every sponsor, half of 259 studies reached it within 38 months; a quarter within 16 and three quarters within 97.
Completion moved once since we started tracking on Sep 25, 2026: Mar 2030 → Mar 2031, on Nov 12, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Cerebral and Cardiovascular Center, Japan